Therapeutic Uses

Amikacin is preferred for the initial treatment of serious nosocomial gram-negative bacillary infections in hospitals where gentamicin and tobramycin resistance is prevalent. Amikacin is active against the vast majority of aerobic gram-negative bacilli, including most strains of Serra-tia, Proteus, and P. aeruginosa. It is active against nearly all strains of Klebsiella, Enterobacter, and E. coli that are resistant to gentamicin and tobramycin. Most resistance to amikacin is found among strains of Acinetobacter, Providencia, and Flavobacter and strains of Pseudomonas other than P. aeruginosa; these all are unusual pathogens. Amikacin is less active than gentamicin against enterococci and should not be used. Amikacin is not active against the majority of grampositive anaerobic bacteria. It is active against M. tuberculosis, including streptomycin-resistant strains, and atypical mycobacteria. It has been used in the treatment of disseminated atypical mycobacterial infection in acquired immunodeficiency syndrome (AIDS) patients.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment